LSPediA Adds Notification Capabilities to Verifier® VRS Solution
Leading drug supply chain solution adds new DSCSA capabilities
By: LSPediA Inc.
"While suspect and recalled drugs are just a small portion of returned products, failing to identify those drugs and document their handling can be a serious liability for a distributor and a danger to the general public," said LSPediA CEO Riya Cao. "The FDA is taking that part of the DSCSA rules very seriously."
The added functionality of LSPediA's Notifier® element manages inbound and outbound notifications for recalled products, suspect products, and investigations. Notifier® also provides automated workflow to initiate quarantines, conduct verification, file FDA 3911 reports, and notify trading partners, as required under the Drug Supply Chain Security Act. All events are captured with a complete history for six years and are easily accessible for audits.
The notification requirements of the DSCSA took on added importance earlier this year when it was revealed that the FDA issued a Form 483 Warning Letter in July to one of the country's largest wholesale distributors. One year earlier, the same distributor was hit with a $150 million fine for mishandling suspicious products. This was the first enforcement action to directly cite DSCSA requirements and has put the pharma industry on alert to fully document and alert the agency and trading partners about suspect and illegitimate products.
LSPediA's Verifier® is already up and running, a stand-alone, turnkey VRS solution that has conducted nearly 50,000 successful scans in the three short months since its release. VRS already has emerged as the preferred platform for verifying returns among trading partner globally and in the U.S., with an eye toward maximizing revenue in the $11 billion market for saleable returns.
For more information or a demonstration of LSPediA's Verifier® Verification Router Service with Notifier®, sign up for our weekly newsletter at https://lspedia.com/
About LSPediA – Life Sciences Solutions
LSPediA is a leading supply chain software provider for the pharmaceutical industry. LSPediA's serialization solution RxChain enables pharmaceutical manufacturers, wholesale distributors, dispensers to manage data, distribute products, and track inventory at the serialized level. LSPediA's Verification Router Service enables authorized trading partners to authenticate serialized products, verify returns, and deter counterfeiting.
To learn more, please call (248) 973-2008, email email@example.com or visit www.lspedia.com.